This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Peng, L. Articles by Payne, A. H. Search for Related Content PubMed PubMed Citation Articles by Peng, L. Articles by Payne, A. H.

Transcription Enhancer Factor-5 and a GATA-Like Protein Determine Placental-Specific Expression of the Type I Human 3ß-Hydroxysteroid Dehydrogenase Gene, HSD3B1

Division of Reproductive Biology (L.P., Y.H., A.H.P.), Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California 94305; and Department of Obstetrics and Gynecology (F.J., S.-W.J.), Mayo Clinic, Rochester, Minnesota 55905

Address all correspondence and requests for reprints to: Dr. Anita H. Payne, Division of Reproductive Biology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, California 94305-5317. E-mail: anita.payne{at}stanford.edu.

The enzyme 3ß-hydroxysteroid dehydrogenase/isomerase (3ßHSD) is required for the biosynthesis of all active steroid hormones. It exists as multiple isoforms in humans and rodents, each a product of a distinct gene. Two isoforms, 3ßHSD I and II, are expressed in a tissue-specific manner in humans. 3ßHSD I is the only isoform expressed in the placenta, where it is required for the biosynthesis of progesterone and thus essential for the maintenance of pregnancy. We recently identified two transcription factors, activating protein-2 (AP-2) and the homeodomain protein, distaless-3 (Dlx-3), that are expressed in both human and mouse trophoblast cells that were shown to be required for trophoblast-specific expression of the orthologous murine 3ßHSD, 3ßHSD VI. Although we identified specific binding sites for AP-2 and Dlx-3 in the distal promoter of the human 3ßHSD I gene, HSD3B1, it was found that these transcription factors were not involved in determining placental-specific expression of human 3ßHSD I. Instead, a 53-bp placental-specific enhancer element located between –2570 and –2518 of the HSD3B1 promoter was identified. Within this 53-bp element, two potential placental transcription factor binding sites were found. EMSAs with a 20-bp oligonucleotide containing these two potential placental-specific binding sites identified one of the binding sites specific for the transcription enhancer factor (TEF)-5, which is highly expressed in human placenta and in placental choriocarcinoma-derived JEG-3 cells and the other overlapping binding site, specific for a GATA-like protein. Site-specific mutations in either the TEF-5 binding site or in the GATA binding site, each resulted in complete loss of enhancer activity. The data indicate that TEF-5 and the GATA-like protein act in a coordinate manner to determine the placental-specific expression of the human 3ßHSD I enzyme and therefore are critical for placental progesterone production required for the maintenance of pregnancy.

This article has been cited by other articles:

				S. Ray, D. Dutta, M. A. K. Rumi, L. N. Kent, M. J. Soares, and S. Paul Context-dependent Function of Regulatory Elements and a Switch in Chromatin Occupancy between GATA3 and GATA2 Regulate Gata2 Transcription during Trophoblast Differentiation J. Biol. Chem., February 20, 2009; 284(8): 4978 - 4988. [Abstract] [Full Text] [PDF]

				M. Chang, D. Mukherjea, R. M. Gobble, K. A. Groesch, R. J. Torry, and D. S. Torry Glial Cell Missing 1 Regulates Placental Growth Factor (PGF) Gene Transcription in Human Trophoblast Biol Reprod, May 1, 2008; 78(5): 841 - 851. [Abstract] [Full Text] [PDF]

				R. S. Viger, S. M. Guittot, M. Anttonen, D. B. Wilson, and M. Heikinheimo Role of the GATA Family of Transcription Factors in Endocrine Development, Function, and Disease Mol. Endocrinol., April 1, 2008; 22(4): 781 - 798. [Abstract] [Full Text] [PDF]

				P. Murthi, V. Doherty, J. Said, S. Donath, S. P. Brennecke, and B. Kalionis Homeobox Gene HLX1Expression Is Decreased in Idiopathic Human Fetal Growth Restriction Am. J. Pathol., February 1, 2006; 168(2): 511 - 518. [Abstract] [Full Text] [PDF]

				L. J. Martin, H. Taniguchi, N. M. Robert, J. Simard, J. J. Tremblay, and R. S. Viger GATA Factors and the Nuclear Receptors, Steroidogenic Factor 1/Liver Receptor Homolog 1, Are Key Mutual Partners in the Regulation of the Human 3{beta}-Hydroxysteroid Dehydrogenase Type 2 Promoter Mol. Endocrinol., September 1, 2005; 19(9): 2358 - 2370. [Abstract] [Full Text] [PDF]

				K A Berghorn, P A Clark, B Encarnacion, C J DeRegis, J K Folger, M I Morasso, M J Soares, M W Wolfe, and M S Roberson Developmental expression of the homeobox protein Distal-less 3 and its relationship to progesterone production in mouse placenta J. Endocrinol., August 1, 2005; 186(2): 315 - 323. [Abstract] [Full Text] [PDF]

				J. Simard, M.-L. Ricketts, S. Gingras, P. Soucy, F. A. Feltus, and M. H. Melner Molecular Biology of the 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase Gene Family Endocr. Rev., June 1, 2005; 26(4): 525 - 582. [Abstract] [Full Text] [PDF]

				A. Kamat, M. E. Smith, J. M. Shelton, J. A. Richardson, and C. R. Mendelson Genomic Regions that Mediate Placental Cell-Specific and Developmental Regulation of Human Cyp19 (Aromatase) Gene Expression in Transgenic Mice Endocrinology, May 1, 2005; 146(5): 2481 - 2488. [Abstract] [Full Text] [PDF]

				A. H. Payne and D. B. Hales Overview of Steroidogenic Enzymes in the Pathway from Cholesterol to Active Steroid Hormones Endocr. Rev., December 1, 2004; 25(6): 947 - 970. [Abstract] [Full Text] [PDF]